Anti-EBV Nuclear Antigen/EBNA1 antibody [E1-2.5],Abcam,AB8329

Host

Mouse

Reactivity

Epstein-Barr virus

Application

IHC-P, ICC, ELISA

Platform ID

BAB475749675

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-EBV Nuclear Antigen/EBNA1 antibody [E1-2.5]
Cat. No.AB8329
HostMouse
IsotypeIgG2b
ReactivityEpstein-Barr virus
ApplicationIHC-P, ICC, ELISA
ClonalityMonoclonal
Clone NumberE1-2.5
Concentration1 mg/mL Batch dependent concentration
ImmunogenSynthetic Peptide within Epstein-Barr Virus (Strain B95-8) EBNA1. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Responsible for the origin of replication (oriP) dependent replication and maintenance of viral episomes during latent infection (PubMed : 15479791, PubMed : 2996781). EBNA1 dimer interacts with the DS (dyad symmetry) element within the origin of replication oriP and with a host mitotic chromosome to initiate viral DNA replication during latency (PubMed : 24067969, PubMed : 2996781, PubMed : 31142669, PubMed : 8551585). EBNA1 binding to DS recruits the host origin recognition complex (ORC) (PubMed : 12953058). Governs the faithful mitotic segregation of the viral episomes by binding both the FR (family of repeats) element within oriP and the host mitotic chromosomes (PubMed : 11172042, PubMed : 15479791, PubMed : 24067969). Forms a cell cycle-dependent tyrosine-dependent DNA cross-link and single-strand cleavage at oriP required for terminating replication and maintaining viral episomes (PubMed : 33482082). Counteracts the stabilization of host p53/TP53 by host USP7, thereby decreasing apoptosis and increasing host cell survival (PubMed : 15808506). Induces degradation of host PML through the ubiquitin-proteasome system, which promotes lytic reactivation and may impair the host cell DNA repair (PubMed : 18833293). Increases the association of CK2 with PML proteins which increases the phosphorylation of PML proteins by CK2, triggering the polyubiquitylation and degradation of PML (PubMed : 20719947). Displays inhibitory effects on a SUMO2-modified complex that includes STUB1, KAP1 and USP7 (PubMed : 32176739). This inhibitory effect possibly participates to the maintenance of latency linked to PML silencing (PubMed : 32176739). See full target information EBNA1

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.